These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 23123167

  • 1. Prenatal treatment of congenital adrenal hyperplasia: risks outweigh benefits.
    Miller WL, Witchel SF.
    Am J Obstet Gynecol; 2013 May; 208(5):354-9. PubMed ID: 23123167
    [Abstract] [Full Text] [Related]

  • 2. Fetal endocrine therapy for congenital adrenal hyperplasia should not be done.
    Miller WL.
    Best Pract Res Clin Endocrinol Metab; 2015 Jun; 29(3):469-83. PubMed ID: 26051303
    [Abstract] [Full Text] [Related]

  • 3. Cognitive functions in children at risk for congenital adrenal hyperplasia treated prenatally with dexamethasone.
    Hirvikoski T, Nordenström A, Lindholm T, Lindblad F, Ritzén EM, Wedell A, Lajic S.
    J Clin Endocrinol Metab; 2007 Feb; 92(2):542-8. PubMed ID: 17148562
    [Abstract] [Full Text] [Related]

  • 4. How safe is long-term prenatal glucocorticoid treatment?
    Seckl JR, Miller WL.
    JAMA; 1997 Apr 02; 277(13):1077-9. PubMed ID: 9091698
    [No Abstract] [Full Text] [Related]

  • 5. The effect on the fetal pituitary-adrenal axis of dexamethasone administration early in the second trimester of pregnancy.
    Mesogitis S, Daskalakis G, Papapetrou P, Mavroudis K, Papandroulaki F, Papantoniou N, Antsaklis A.
    J Matern Fetal Neonatal Med; 2011 Jan 02; 24(1):109-12. PubMed ID: 20528220
    [Abstract] [Full Text] [Related]

  • 6. Congenital adrenal hyperplasia: do the benefits of prenatal treatment defeat the risks?
    Vos AA, Bruinse HW.
    Obstet Gynecol Surv; 2010 Mar 02; 65(3):196-205. PubMed ID: 20214835
    [Abstract] [Full Text] [Related]

  • 7. Prenatal dexamethasone treatment of fetuses at risk for congenital adrenal hyperplasia: benefits and concerns.
    Ritzén EM.
    Semin Neonatol; 2001 Aug 02; 6(4):357-62. PubMed ID: 11972437
    [Abstract] [Full Text] [Related]

  • 8. Dexamethasone treatment of congenital adrenal hyperplasia in utero: an experimental therapy of unproven safety.
    Miller WL.
    J Urol; 1999 Aug 02; 162(2):537-40. PubMed ID: 10411085
    [Abstract] [Full Text] [Related]

  • 9. Prenatal dexamethasone treatment of children at risk for congenital adrenal hyperplasia: the Swedish experience and standpoint.
    Hirvikoski T, Nordenström A, Wedell A, Ritzén M, Lajic S.
    J Clin Endocrinol Metab; 2012 Jun 02; 97(6):1881-3. PubMed ID: 22466333
    [No Abstract] [Full Text] [Related]

  • 10. An update on prenatal diagnosis and treatment of congenital adrenal hyperplasia.
    New MI, Abraham M, Yuen T, Lekarev O.
    Semin Reprod Med; 2012 Oct 02; 30(5):396-9. PubMed ID: 23044876
    [Abstract] [Full Text] [Related]

  • 11. Preventing female virilisation in congenital adrenal hyperplasia: The controversial role of antenatal dexamethasone.
    Heland S, Hewitt JK, McGillivray G, Walker SP.
    Aust N Z J Obstet Gynaecol; 2016 Jun 02; 56(3):225-32. PubMed ID: 26661642
    [Abstract] [Full Text] [Related]

  • 12. First-Trimester Prenatal Dexamethasone Treatment Is Associated With Alterations in Brain Structure at Adult Age.
    Van't Westeinde A, Karlsson L, Nordenström A, Padilla N, Lajic S.
    J Clin Endocrinol Metab; 2020 Aug 01; 105(8):2575-86. PubMed ID: 32497228
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Maternal side effects of prenatal dexamethasone therapy for fetal congenital adrenal hyperplasia.
    Pang S, Clark AT, Freeman LC, Dolan LM, Immken L, Mueller OT, Stiff D, Shulman DI.
    J Clin Endocrinol Metab; 1992 Jul 01; 75(1):249-53. PubMed ID: 1619017
    [Abstract] [Full Text] [Related]

  • 16. Sex-Dimorphic Effects of Prenatal Treatment With Dexamethasone.
    Wallensteen L, Zimmermann M, Thomsen Sandberg M, Gezelius A, Nordenström A, Hirvikoski T, Lajic S.
    J Clin Endocrinol Metab; 2016 Oct 01; 101(10):3838-3846. PubMed ID: 27482827
    [Abstract] [Full Text] [Related]

  • 17. Prenatal Treatment of Congenital Adrenal Hyperplasia: Long-Term Effects of Excess Glucocorticoid Exposure.
    Lajic S, Karlsson L, Nordenström A.
    Horm Res Paediatr; 2018 Oct 01; 89(5):362-371. PubMed ID: 29742490
    [Abstract] [Full Text] [Related]

  • 18. Exposure to Glucocorticoids in the First Part of Fetal Life is Associated with Insulin Secretory Defect in Adult Humans.
    Riveline JP, Baz B, Nguewa JL, Vidal-Trecan T, Ibrahim F, Boudou P, Vicaut E, Brac de la Perrière A, Fetita S, Bréant B, Blondeau B, Tardy-Guidollet V, Morel Y, Gautier JF.
    J Clin Endocrinol Metab; 2020 Mar 01; 105(3):. PubMed ID: 31665349
    [Abstract] [Full Text] [Related]

  • 19. Prenatal diagnosis and management of congenital adrenal hyperplasia.
    Speiser PW, New MI.
    Clin Perinatol; 1994 Sep 01; 21(3):631-45. PubMed ID: 7982338
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.